摘要
Immunotherapy for cancer represents a groundbreaking treatment paradigm leveraging the body's immune system to recognize,target,and eradicate cancer cells.1 Nowadays,immunotherapy has demonstrated significant efficacy in addressing diverse cancer types,sometimes achieving long-term remission or even cure in patients who haven't re-sponded to traditional treatments like chemotherapy or radiation.2 However,it's important to note that while im-munotherapy has had groundbreaking success in many cases,it doesn't work for everyone,and ongoing research aims to improve its effectiveness and applicability across different cancer types and patient populations.
基金
supported by the National Key Research and Development Program of China(2020YFA0908200)
the National Natural Science Foundation of China(52103196,32201118,and 52073060)
the Guangdong Basic and Applied Basic Research Foundation(2021B1515120054)
the Wenzhou Institute UCAS startup fund(WIUCASQD2023010).
作者简介
Corresponding author:Gaizhen Kuang,E-mail address:gzhkuang@163.com;Corresponding author:Yuanjin Zhao,yjzhao@seu.edu.cn
